Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases

OBJECTIVE: The extent to which tryptophan (Trp) metabolism alterations explain or influence the outcome of inflammatory bowel diseases (IBDs) is still unclear. However, several Trp metabolism end-products are essential to intestinal homeostasis. Here, we investigated the role of metabolites from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Michaudel, Chloé, Danne, Camille, Agus, Allison, Magniez, Aurélie, Aucouturier, Anne, Spatz, Madeleine, Lefevre, Antoine, Kirchgesner, Julien, Rolhion, Nathalie, Wang, Yazhou, Lavelle, Aonghus, Galbert, Chloé, Da Costa, Gregory, Poirier, Maxime, Lapière, Alexia, Planchais, Julien, Nádvorník, Petr, Illes, Peter, Oeuvray, Cyriane, Creusot, Laura, Michel, Marie-Laure, Benech, Nicolas, Bourrier, Anne, Nion-Larmurier, Isabelle, Landman, Cecilia, Richard, Mathias L, Emond, Patrick, Seksik, Philippe, Beaugerie, Laurent, Arguello, Rafael Rose, Moulin, David, Mani, Sridhar, Dvorák, Zdenek, Bermúdez-Humarán, Luis G, Langella, Philippe, Sokol, Harry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314090/
https://www.ncbi.nlm.nih.gov/pubmed/36270778
http://dx.doi.org/10.1136/gutjnl-2022-327337

Ejemplares similares

Ejemplares similares